Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for OMER

Stock NameOmeros Corporation
TickerOMER(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6821431029
LEI549300CJWLXX2MXVVV71

Show aggregate OMER holdings

News associated with OMER

Omeros (NASDAQ:OMER) Given “Buy” Rating at D. Boral Capital
D. Boral Capital restated their buy rating on shares of Omeros (NASDAQ:OMER – Free Report) in a report published on Wednesday,Benzinga reports. The brokerage currently has a $36.00 price target on the biopharmaceutical company’s stock. OMER has been the subject of a number of other research reports. Needham & Company LLC reissued a “hold” rating […] - 2025-09-04 05:17:02
New York State Common Retirement Fund Has $94,000 Stock Holdings in Omeros Corporation (NASDAQ:OMER)
New York State Common Retirement Fund lessened its position in Omeros Corporation (NASDAQ:OMER – Free Report) by 34.1% during the first quarter, Holdings Channel reports. The institutional investor owned 11,413 shares of the biopharmaceutical company’s stock after selling 5,900 shares during the quarter. New York State Common Retirement Fund’s holdings in Omeros were worth $94,000 […] - 2025-07-28 04:58:50
Brokerages Set Omeros Corporation (NASDAQ:OMER) PT at $18.00
Shares of Omeros Corporation (NASDAQ:OMER – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six research firms that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has issued a strong buy […] - 2025-07-14 02:56:47
Omeros (NASDAQ:OMER) Receives Buy Rating from D. Boral Capital
Omeros (NASDAQ:OMER – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at D. Boral Capital in a report issued on Monday,Benzinga reports. They currently have a $36.00 price target on the biopharmaceutical company’s stock. Several other analysts have also commented on OMER. HC Wainwright began coverage on shares of Omeros in a […] - 2025-07-02 03:02:59
Brighton Jones LLC Grows Stock Holdings in Omeros Corporation (NASDAQ:OMER)
Brighton Jones LLC lifted its holdings in Omeros Corporation (NASDAQ:OMER – Free Report) by 11.3% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 30,714 shares of the biopharmaceutical company’s stock after purchasing an additional 3,125 shares during the period. Brighton Jones LLC’s holdings in Omeros were worth […] - 2025-06-19 05:22:54
Analysts Set Omeros Corporation (NASDAQ:OMER) Target Price at $18.00
Omeros Corporation (NASDAQ:OMER – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the […] - 2025-06-19 02:46:58
HC Wainwright Begins Coverage on Omeros (NASDAQ:OMER)
Analysts at HC Wainwright began coverage on shares of Omeros (NASDAQ:OMER – Get Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The brokerage set a “buy” rating and a $9.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s target price indicates a potential upside of 148.62% from the stock’s […] - 2025-06-12 02:18:56
Friday's ETF with Unusual Volume: XPH
The SPDR S&P Pharmaceuticals ETF is seeing unusually high volume in afternoon trading Friday, with over 318,000 shares traded versus three month average volume of about 57,000. Shares of XPH were up about 1.5% on the day. Components of that ETF with the highest volume on - 2025-06-06 13:49:47
Nuveen Asset Management LLC Sells 9,441 Shares of Omeros Co. (NASDAQ:OMER)
Nuveen Asset Management LLC reduced its position in Omeros Co. (NASDAQ:OMER – Free Report) by 8.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 102,921 shares of the biopharmaceutical company’s stock after selling 9,441 shares during the period. Nuveen […] - 2025-06-05 04:56:52
Omeros (NASDAQ:OMER) Raised to “Hold” at StockNews.com
Omeros (NASDAQ:OMER – Get Free Report) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Monday. Several other analysts have also recently commented on the stock. D. Boral Capital reissued a “buy” rating and set a $36.00 price target on shares of Omeros in […] - 2025-05-21 02:30:48
Omeros Co. (NASDAQ:OMER) Receives $22.50 Consensus Price Target from Brokerages
Omeros Co. (NASDAQ:OMER – Get Free Report) has earned an average rating of “Moderate Buy” from the five ratings firms that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has given a strong buy recommendation to the […] - 2025-04-30 02:10:58
ExodusPoint Capital Management LP Sells 29,216 Shares of Omeros Co. (NASDAQ:OMER)
ExodusPoint Capital Management LP lowered its stake in shares of Omeros Co. (NASDAQ:OMER – Free Report) by 65.3% during the fourth quarter, HoldingsChannel reports. The fund owned 15,495 shares of the biopharmaceutical company’s stock after selling 29,216 shares during the quarter. ExodusPoint Capital Management LP’s holdings in Omeros were worth $153,000 as of its most […] - 2025-04-15 05:10:53
New York State Common Retirement Fund Buys 12,300 Shares of Omeros Co. (NASDAQ:OMER)
New York State Common Retirement Fund grew its stake in Omeros Co. (NASDAQ:OMER – Free Report) by 245.4% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 17,313 shares of the biopharmaceutical company’s stock after buying an additional 12,300 shares during the period. New York State Common Retirement Fund’s holdings in Omeros were worth […] - 2025-03-06 08:25:35
China Universal Asset Management Co. Ltd. Acquires New Holdings in Omeros Co. (NASDAQ:OMER)
China Universal Asset Management Co. Ltd. acquired a new stake in Omeros Co. (NASDAQ:OMER – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 12,287 shares of the biopharmaceutical company’s stock, valued at approximately $121,000. Other institutional investors have also made changes to their […] - 2025-02-04 07:03:05

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) OMER holdings

DateNumber of OMER Shares HeldBase Market Value of OMER SharesLocal Market Value of OMER SharesChange in OMER Shares HeldChange in OMER Base ValueCurrent Price per OMER Share HeldPrevious Price per OMER Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of OMER by Blackrock for IE00BYXG2H39

Show aggregate share trades of OMER

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY3184.6104.720 4.709USD 1,497 5.84
2025-10-03BUY7424.5804.590 4.589USD 3,405 5.85
2025-10-02BUY1064.2204.240 4.238USD 449 5.85
2025-09-30BUY2124.1004.180 4.172USD 884 5.87
2025-09-26BUY2124.4604.520 4.514USD 957 5.89
2025-09-25BUY2124.3804.410 4.407USD 934 5.90
2025-09-24BUY14.2004.360 4.344USD 4 5.91
2025-09-18BUY1054.2604.290 4.287USD 450 5.92
2025-09-17BUY3184.0604.220 4.204USD 1,337 5.93
2025-09-11SELL-1064.2004.330 4.317USD -458 5.97 Profit of 175 on sale
2025-09-10BUY2124.2704.340 4.333USD 919 5.98
2025-09-05SELL-1064.1704.280 4.269USD -453 6.01 Profit of 185 on sale
2025-08-29SELL-3184.1604.240 4.232USD -1,346 6.06 Profit of 580 on sale
2025-08-27BUY2124.2504.400 4.385USD 930 6.08
2025-08-26SELL-1064.3804.460 4.452USD -472 6.09 Profit of 174 on sale
2025-08-25BUY1064.3504.580 4.557USD 483 6.10
2025-08-20SELL-4204.1904.300 4.289USD -1,801 6.12 Profit of 770 on sale
2025-08-18BUY2084.2204.550 4.517USD 940 6.15
2025-08-08SELL-2084.0604.060 4.060USD -844 6.21 Profit of 448 on sale
2025-08-05BUY1044.0204.040 4.038USD 420 6.26
2025-08-01SELL-3093.6103.830 3.808USD -1,177 6.29 Profit of 768 on sale
2025-07-30BUY4123.8504.110 4.084USD 1,683 6.33
2025-07-17SELL-2083.4803.690 3.669USD -763 6.50 Profit of 589 on sale
2025-07-11SELL-8483.6503.790 3.776USD -3,202 6.59 Profit of 2,384 on sale
2025-07-07BUY3183.0803.170 3.161USD 1,005 6.69
2025-07-02BUY5,7753.0903.250 3.234USD 18,676 6.78
2025-06-25BUY2103.5003.600 3.590USD 754 6.89
2025-06-11BUY2103.6204.000 3.962USD 832 7.22
2025-06-10BUY2103.8804.060 4.042USD 849 7.25
2025-06-04SELL-1053.3403.400 3.394USD -356 7.39 Profit of 420 on sale
2025-04-23BUY1036.9707.670 7.600USD 783 8.38
2025-04-10SELL-8245.8606.460 6.400USD -5,274 8.61 Profit of 1,821 on sale
2025-04-08SELL-1036.0307.240 7.119USD -733 8.68 Profit of 161 on sale
2025-04-07SELL-1036.9007.180 7.152USD -737 8.71 Profit of 161 on sale
2025-04-04SELL-5157.0607.510 7.465USD -3,844 8.74 Profit of 656 on sale
2025-04-01BUY4207.9109.160 9.035USD 3,795 8.76
2025-03-31SELL-3128.2208.530 8.499USD -2,652 8.77 Profit of 86 on sale
2025-03-21BUY2,8669.1009.390 9.361USD 26,829 8.76
2025-03-14SELL-1,5208.4208.540 8.528USD -12,963 8.76 Profit of 353 on sale
2025-03-07SELL-1907.6607.750 7.741USD -1,471 8.90 Profit of 219 on sale
2025-03-04SELL-957.9808.090 8.079USD -768 8.97 Profit of 84 on sale
2025-02-25BUY1908.4508.840 8.801USD 1,672 9.04
2025-02-19SELL-949.2509.630 9.592USD -902 9.02 Loss of -54 on sale
2025-02-13BUY2829.1209.200 9.192USD 2,592 9.00
2025-02-12BUY948.5408.870 8.837USD 831 9.01
2025-02-11BUY3768.7208.760 8.756USD 3,292 9.02
2025-01-17BUY3729.3309.570 9.546USD 3,551 9.24
2025-01-16BUY3769.1809.490 9.459USD 3,557 9.25
2025-01-10SELL-1868.8409.880 9.776USD -1,818 9.87 Profit of 18 on sale
2025-01-08SELL-3729.89010.380 10.331USD -3,843 9.84 Loss of -183 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of OMER

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1974,8440249,19830.0%
2025-09-1877,3730311,20024.9%
2025-09-1748,1720468,24410.3%
2025-09-1681,5220292,03627.9%
2025-09-1592,303700261,44235.3%
2025-09-1288,4574,033220,82040.1%
2025-09-11101,2851,985320,15931.6%
2025-09-1075,4327,166454,44316.6%
2025-09-09101,7390233,03643.7%
2025-09-0899,3670241,02741.2%
2025-09-0586,7860223,38738.9%
2025-09-0475,6470244,29731.0%
2025-09-03138,3105322,51142.9%
2025-09-0291,8290362,79725.3%
2025-08-2984,2360221,65338.0%
2025-08-2849,3940171,19928.9%
2025-08-2759,5770138,45343.0%
2025-08-26100,8170322,24931.3%
2025-08-25145,7082,200378,88638.5%
2025-08-2296,040857392,98124.4%
2025-08-21265,8940618,87443.0%
2025-08-20109,7600327,12133.6%
2025-08-19330,474300957,20834.5%
2025-08-18172,854779489,74935.3%
2025-08-15281,9072,6081,014,08927.8%
2025-08-14155,137600319,73548.5%
2025-08-13117,7510448,46026.3%
2025-08-12100,9140250,45740.3%
2025-08-11131,3025,555307,00642.8%
2025-08-08173,7330332,08752.3%
2025-08-07100,1990185,46354.0%
2025-08-06186,1990289,11564.4%
2025-08-05320,2842,244562,27357.0%
2025-08-04306,4916,200695,03744.1%
2025-08-01425,6791,733812,24152.4%
2025-07-31223,1000402,43655.4%
2025-07-30309,65229,629565,27354.8%
2025-07-29339,4860709,35747.9%
2025-07-281,620,4962692,889,25556.1%
2025-07-251,411,7151,1192,725,89951.8%
2025-07-24144,1110232,59962.0%
2025-07-23180,1750290,29862.1%
2025-07-22144,6780272,14153.2%
2025-07-21357,9560586,42261.0%
2025-07-18145,451893303,24948.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.


Copyright Market Footprint Ltd. Privacy Policy